BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30987892)

  • 1. A cross-linking approach to map small molecule-RNA binding sites in cells.
    Velagapudi SP; Li Y; Disney MD
    Bioorg Med Chem Lett; 2019 Jun; 29(12):1532-1536. PubMed ID: 30987892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A general fragment-based approach to identify and optimize bioactive ligands targeting RNA.
    Suresh BM; Li W; Zhang P; Wang KW; Yildirim I; Parker CG; Disney MD
    Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33197-33203. PubMed ID: 33318191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying and validating small molecules interacting with RNA (SMIRNAs).
    Disney MD; Velagapudi SP; Li Y; Costales MG; Childs-Disney JL
    Methods Enzymol; 2019; 623():45-66. PubMed ID: 31239057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of a small molecule against an oncogenic noncoding RNA.
    Velagapudi SP; Cameron MD; Haga CL; Rosenberg LH; Lafitte M; Duckett DR; Phinney DG; Disney MD
    Proc Natl Acad Sci U S A; 2016 May; 113(21):5898-903. PubMed ID: 27170187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Molecule Inhibition of microRNA-210 Reprograms an Oncogenic Hypoxic Circuit.
    Costales MG; Haga CL; Velagapudi SP; Childs-Disney JL; Phinney DG; Disney MD
    J Am Chem Soc; 2017 Mar; 139(9):3446-3455. PubMed ID: 28240549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining RNA-Small Molecule Affinity Landscapes Enables Design of a Small Molecule Inhibitor of an Oncogenic Noncoding RNA.
    Velagapudi SP; Luo Y; Tran T; Haniff HS; Nakai Y; Fallahi M; Martinez GJ; Childs-Disney JL; Disney MD
    ACS Cent Sci; 2017 Mar; 3(3):205-216. PubMed ID: 28386598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs.
    Velagapudi SP; Costales MG; Vummidi BR; Nakai Y; Angelbello AJ; Tran T; Haniff HS; Matsumoto Y; Wang ZF; Chatterjee AK; Childs-Disney JL; Disney MD
    Cell Chem Biol; 2018 Sep; 25(9):1086-1094.e7. PubMed ID: 30251629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hide and seek: Identification and confirmation of small molecule protein targets.
    Ursu A; Waldmann H
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3079-86. PubMed ID: 26115575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLIP-seq to discover transcriptome-wide imprinting of RNA binding proteins in living cells.
    Saulière J; Le Hir H
    Methods Mol Biol; 2015; 1296():151-60. PubMed ID: 25791598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of RNA template to a complex of HIV-1 reverse transcriptase/primer/template.
    Canard B; Sarfati R; Richardson CC
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11279-84. PubMed ID: 9326600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precise small-molecule recognition of a toxic CUG RNA repeat expansion.
    Rzuczek SG; Colgan LA; Nakai Y; Cameron MD; Furling D; Yasuda R; Disney MD
    Nat Chem Biol; 2017 Feb; 13(2):188-193. PubMed ID: 27941760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to Validate and Manipulate RNA Targets with Small Molecules in Cells.
    Childs-Disney JL; Disney MD
    Annu Rev Pharmacol Toxicol; 2016; 56():123-40. PubMed ID: 26514201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of photo-cross-linked small molecule affinity matrices for affinity selection of protein targets for biologically active small molecules.
    Takayama H; Moriya T; Kanoh N
    Methods Mol Biol; 2012; 800():75-83. PubMed ID: 21964783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using SHAPE-MaP to probe small molecule-RNA interactions.
    Martin S; Blankenship C; Rausch JW; Sztuba-Solinska J
    Methods; 2019 Sep; 167():105-116. PubMed ID: 31009771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of RNA accessible sites by extension of random oligonucleotide libraries with reverse transcriptase.
    Allawi HT; Dong F; Ip HS; Neri BP; Lyamichev VI
    RNA; 2001 Feb; 7(2):314-27. PubMed ID: 11233988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches to map small molecule-target interactions.
    Kapoor S; Waldmann H; Ziegler S
    Bioorg Med Chem; 2016 Aug; 24(15):3232-45. PubMed ID: 27240466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precise Small Molecule Degradation of a Noncoding RNA Identifies Cellular Binding Sites and Modulates an Oncogenic Phenotype.
    Li Y; Disney MD
    ACS Chem Biol; 2018 Nov; 13(11):3065-3071. PubMed ID: 30375843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual Nucleotide Resolution UV Cross-Linking and Immunoprecipitation (iCLIP) to Determine Protein-RNA Interactions.
    Sibley CR
    Methods Mol Biol; 2018; 1649():427-454. PubMed ID: 29130215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational Design of Small Molecules Targeting Oncogenic Noncoding RNAs from Sequence.
    Disney MD; Angelbello AJ
    Acc Chem Res; 2016 Dec; 49(12):2698-2704. PubMed ID: 27993012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric "beta-blocker" isolated from a DNA-encoded small molecule library.
    Ahn S; Kahsai AW; Pani B; Wang QT; Zhao S; Wall AL; Strachan RT; Staus DP; Wingler LM; Sun LD; Sinnaeve J; Choi M; Cho T; Xu TT; Hansen GM; Burnett MB; Lamerdin JE; Bassoni DL; Gavino BJ; Husemoen G; Olsen EK; Franch T; Costanzi S; Chen X; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1708-1713. PubMed ID: 28130548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.